197 related articles for article (PubMed ID: 38038121)
1.
Sun R; Han M; Liu Y; Su Y; Shi Q; Huang L; Kong L; Li W; Li W
Mol Med Rep; 2024 Jan; 29(1):. PubMed ID: 38038121
[TBL] [Abstract][Full Text] [Related]
2. Trpc6 knockout improves behavioral dysfunction and reduces Aβ production by inhibiting CN-NFAT1 signaling in T2DM mice.
Kong L; Sun R; Zhou H; Shi Q; Liu Y; Han M; Li W; Qun S; Li W
Exp Neurol; 2023 May; 363():114350. PubMed ID: 36791875
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg1 attenuates glomerular fibrosis by inhibiting CD36/TRPC6/NFAT2 signaling in type 2 diabetes mellitus mice.
Han Y; Su Y; Han M; Liu Y; Shi Q; Li X; Wang P; Li W; Li W
J Ethnopharmacol; 2023 Feb; 302(Pt A):115923. PubMed ID: 36375645
[TBL] [Abstract][Full Text] [Related]
4. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
Ilatovskaya DV; Blass G; Palygin O; Levchenko V; Pavlov TS; Grzybowski MN; Winsor K; Shuyskiy LS; Geurts AM; Cowley AW; Birnbaumer L; Staruschenko A
J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963
[No Abstract] [Full Text] [Related]
5. Protective role of Trpc6 knockout in the progression of diabetic kidney disease.
Spires D; Ilatovskaya DV; Levchenko V; North PE; Geurts AM; Palygin O; Staruschenko A
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1091-F1097. PubMed ID: 29923767
[TBL] [Abstract][Full Text] [Related]
6. Cortex Mori Radicis Attenuates Streptozotocin-induced Diabetic Renal Injury in Mice
Zhai Y; Li D; Wang Z; Shao L; Yin N; Li W
Endocr Metab Immune Disord Drug Targets; 2022; 22(8):862-873. PubMed ID: 35016601
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J
Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of TRPC6 channels ameliorates renal fibrosis and contributes to renal protection by soluble klotho.
Wu YL; Xie J; An SW; Oliver N; Barrezueta NX; Lin MH; Birnbaumer L; Huang CL
Kidney Int; 2017 Apr; 91(4):830-841. PubMed ID: 27979597
[TBL] [Abstract][Full Text] [Related]
9. Palmitate induces human glomerular mesangial cells fibrosis through CD36-mediated transient receptor potential canonical channel 6/nuclear factor of activated T cell 2 activation.
Su Y; Chen Q; Ju Y; Li W; Li W
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158793. PubMed ID: 32800850
[TBL] [Abstract][Full Text] [Related]
10. TRPC Channels in Proteinuric Kidney Diseases.
Hall G; Wang L; Spurney RF
Cells; 2019 Dec; 9(1):. PubMed ID: 31877991
[TBL] [Abstract][Full Text] [Related]
11. Knockout of TRPC6 promotes insulin resistance and exacerbates glomerular injury in Akita mice.
Wang L; Chang JH; Buckley AF; Spurney RF
Kidney Int; 2019 Feb; 95(2):321-332. PubMed ID: 30665571
[TBL] [Abstract][Full Text] [Related]
12. Canonical Transient Receptor Potential 6 Channel: A New Target of Reactive Oxygen Species in Renal Physiology and Pathology.
Ma R; Chaudhari S; Li W
Antioxid Redox Signal; 2016 Nov; 25(13):732-748. PubMed ID: 26937558
[TBL] [Abstract][Full Text] [Related]
13. Renal Fibrosis, Immune Cell Infiltration and Changes of TRPC Channel Expression after Unilateral Ureteral Obstruction in Trpc6-/- Mice.
Kong W; Haschler TN; Nürnberg B; Krämer S; Gollasch M; Markó L
Cell Physiol Biochem; 2019; 52(6):1484-1502. PubMed ID: 31099508
[TBL] [Abstract][Full Text] [Related]
14. TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription.
Schlöndorff J; Del Camino D; Carrasquillo R; Lacey V; Pollak MR
Am J Physiol Cell Physiol; 2009 Mar; 296(3):C558-69. PubMed ID: 19129465
[TBL] [Abstract][Full Text] [Related]
15. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T
J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli.
Ilatovskaya DV; Palygin O; Chubinskiy-Nadezhdin V; Negulyaev YA; Ma R; Birnbaumer L; Staruschenko A
Kidney Int; 2014 Sep; 86(3):506-14. PubMed ID: 24646854
[TBL] [Abstract][Full Text] [Related]
17. The Effects of TRPC6 Knockout in Animal Models of Kidney Disease.
Dryer SE; Kim EY
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421724
[TBL] [Abstract][Full Text] [Related]
18. Capsazepine (CPZ) Inhibits TRPC6 Conductance and Is Protective in Adriamycin-Induced Nephropathy and Diabetic Glomerulopathy.
Hagmann H; Khayyat NH; Matin M; Oezel C; Chen H; Schauss A; Schell C; Benzing T; Dryer S; Brinkkoetter PT
Cells; 2023 Jan; 12(2):. PubMed ID: 36672207
[TBL] [Abstract][Full Text] [Related]
19. Role of TRPC6 in Progression of Diabetic Kidney Disease.
Staruschenko A; Spires D; Palygin O
Curr Hypertens Rep; 2019 May; 21(7):48. PubMed ID: 31115705
[TBL] [Abstract][Full Text] [Related]
20. Transient receptor potential canonical 6 knockdown ameliorated diabetic kidney disease by inhibiting nuclear factor of activated T cells 2 expression in glomerular mesangial cells.
Yu J; Li C; Ma L; Zhai B; Xu A; Shao D
Ren Fail; 2022 Dec; 44(1):1780-1790. PubMed ID: 36285371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
